nach oben

Erschienen in:

27.03.2017 | Review Article

Basic and important points regarding the diagnosis of oral cancers using fluorine-18-labeled fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography: a review

verfasst von: Shinji Kito, Hirofumi Koga, Masafumi Oda, Tatsurou Tanaka, Masaaki Kodama, Manabu Habu, Ikuya Miyamoto, Shinya Kokuryo, Noriaki Yamamoto, Nao Wakasugi-Sato, Shinobu Matsumoto-Takeda, Daigo Yoshiga, Kenji Osawa, Shun Nishimura, Takaaki Joujima, Ken-ichi Mochida, Noriaki Kawanabe, Kou Matsuo, Masataka Uehara, Masaaki Sasaguri, Izumi Yoshioka, Kazuhiro Tominaga, Yasuhiro Morimoto

Erschienen in: Oral Radiology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Numerous studies, including our own, have revealed that positron emission tomography–computed tomography (PET/CT) using fluorine-18-labeled fluoro-2-deoxy-d-glucose (¹⁸F-FDG) is effective for the diagnosis of oral cancers. Large amounts of new information about primary tumors and metastatic lymph nodes have been acquired, and the use of ¹⁸F-FDG PET/CT has been shown to improve diagnostic precision in determining both the pathological characteristics of primary oral cancers and the presence of metastatic lymph nodes. However, substantial variations in ¹⁸F-FDG uptake in the oral and maxillofacial regions have been identified, and the differential diagnosis of some oral cancers and metastatic lymph nodes remains difficult for radiologists. Therefore, based on the previous research, the aim of the present study was to review the basic and important points regarding the diagnosis of primary oral cancers and metastatic lymph nodes using ¹⁸F-FDG PET/CT.

Kim SJ, Chang S. Volumetric parameters changes of sequential ¹⁸F-FDG PET/CT for early prediction of recurrence and death in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. Clin Nucl Med. 2015;40:930–5.CrossRefPubMed

Wei J, Pei S, Zhu X. Comparison of ¹⁸F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: a meta-analysis. Oral Oncol. 2016;52:11–7.CrossRefPubMed

Müller J, Hüllner M, Strobel K, Huber GF, Burger IA, Haerle SK. The value of (¹⁸) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction. Laryngoscope. 2015;125:1861–8.CrossRefPubMed

Kito S, Koga H, Kodama M, Habu M, Kokuryo S, Oda M, et al. Alterations in ¹⁸F-FDG accumulation into neck-related muscles after neck dissection for patients with oral cancers. Med Oral Patol Oral Cir Bucal. 2016;21:e341–e8.CrossRefPubMedPubMedCentral

Meeuwis J, Hoekstra OS, Witte BI, Boellaard R, Leemans CR, de Bree R. 18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients. Oral Oncol. 2015;51:536–40.CrossRefPubMed

Pasha MA, Marcus C, Fakhry C, Kang H, Kiess AP, Subramaniam RM. FDG PET/CT for management and assessing outcomes of squamous cell cancer of the oral cavity. Am J Roentgenol. 2015;205:W150–W61.CrossRef

Gao S, Li S, Yang X, Tang Q. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis. Oral Oncol. 2014;50:163–7.CrossRefPubMed

Xu GZ, Guan DJ, He ZY. (¹⁸)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol. 2011;47:560–5.CrossRefPubMed

Kito S, Koga H, Kodama M, Habu M, Kokuryo S, Yamamoto N, et al. Variety and complexity of ¹⁸F-FDG accumulations in oral cavity of patients with oral cancers. Dentomaxillofac Radiol. 2013;42:20130014. doi:10.1259/dmfr.20130014.CrossRefPubMedPubMedCentral

10.

Kito S, Koga H, Kodama M, Yamamoto N, Kokuryo S, Habu M, et al. Reflection of ¹⁸F-FDG accumulation in the evaluation of the extent of periapical or periodontal inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:e62–e9.CrossRefPubMed

11.

Kito S, Koga H, Oda M, Tanaka T, Kodama M, Habu M, et al. The important pitfalls in the diagnosis of cancer in the oral cavity using ¹⁸F-FDG-PET-CT. In: Horizons in cancer research. Hauppague: Nova Science Publishers; 2015. pp. 85–96.

12.

Oda M, Tanaka T, Kito S, Seta Y, Ishikawa A, Kodama M, et al. Recent advances of the diagnostic images for oral cancers. In: Oral cancer: causes, diagnosis and treatment. Hauppague: Nova Science Publishers; 2011.

13.

Kowalsky RJ, Falen SW, editors. Radiopharmaceuticals in nuclear pharmacy and nuclear medicine. 2nd ed. Washington, DC: American Pharmacists Association; 2004.

14.

Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–59.CrossRefPubMed

15.

Shreve PD, Bui CDH. Normal variants in FDG PET imaging. In: Wahl RL, editor. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins; 2002. pp. 111–36.

16.

Roh JL, Ryu CH, Choi SH, Kim JS, Lee JH, Cho KJ, et al. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. J Nucl Med. 2007;48:240–6.PubMed

17.

Islam T, Harisinghani MG. Overview of nanoparticle use in cancer imaging. Cancer Biomark. 2009;5:61–7.CrossRefPubMed

18.

Lee C, Langen KM, Lu W, Haimerl J, Schnarr E, Ruchala KJ, et al. Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration. Radiother Oncol. 2008;89:81–8.CrossRefPubMed

19.

Gupta T, Beriwal S. PET/CT-guided radiation therapy planning: from present to the future. Indian J Cancer. 2010;47:126–33.CrossRefPubMed

20.

Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, et al. Utility of 2-[¹⁸F] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol. 2007;43:887–93.CrossRefPubMed

21.

Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:129–36.CrossRefPubMed

22.

Andrade RS, Heron DE, Degirmenci B, Filho PA, Branstetter BF, Seethala RR, et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006;65:1315–22.CrossRefPubMed

23.

Suzuki H, Fukuyama R, Hasegawa Y, Tamaki T, Nishio M, Nakashima T, et al. Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas. Oral Oncol. 2009;45:891–7.CrossRefPubMed

24.

Chung MK, Jeong HS, Son YI, So YK, Park GY, Choi JY, et al. Metabolic tumor volumes by [¹⁸F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue. Ann Surg Oncol. 2009;16:3111–7.CrossRefPubMed

25.

Miyawaki A, Ikeda R, Hijioka H, Ishida T, Ushiyama M, Nozoe E, et al. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma. Oncol Rep. 2010;23:1205–12.CrossRefPubMed

26.

Suzuki H, Hasegawa Y, Terada A, Hyodo I, Nakashima T, Nishio M, et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol. 2009;45:569–73.CrossRefPubMed

27.

Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging. 2004;31:590–5.CrossRefPubMed

28.

Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG, et al. ¹⁸F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med. 2009;50:1940–7.CrossRefPubMed

29.

McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Scapular muscle exercises following neck dissection surgery for head and neck cancer: a comparative electromyographic study. Phys Ther. 2013;93:786–97.CrossRefPubMed

30.

McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Impact of neck dissection on scapular muscle function: a case-controlled electromyographic study. Arch Phys Med Rehabil. 2013;94:113–9.CrossRefPubMed

31.

McGarvey AC, Chiarelli PE, Osmotherly PG, Hoffman GR. Physiotherapy for accessory nerve shoulder dysfunction following neck dissection surgery: a literature review. Head Neck. 2011;33:274–80.CrossRefPubMed

32.

Andreadis D, Stylianou F, Link-Tsatsouli I, Markopoulos A. Bilateral masseter and internal pterygoid muscle hypertrophy: a diagnostic challenge. Med Princ Pract. 2014;23:286–8.CrossRefPubMed

33.

Ariji Y, Fuwa N, Kodaira T, Tachibana H, Nakamura T, Satoh Y, et al. False-positive positron emission tomography appearance with 18F-fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue. Br J Radiol. 2009;82:e3–e7.CrossRefPubMed

34.

Bogsrud TV, Lowe VJ. Normal variants and pitfalls in whole-body PET imaging with 18F FDG. Appl Radiol.0. 2006;35:16–30.

35.

Shimamoto H, Tatsumi M, Kakimoto N, Hamada S, Shimosegawa E, Murakami S, et al. (18)F-FDG accumulation in the oral cavity is associated with periodontal disease and apical periodontitis: an initial demonstration on PET/CT. Ann Nucl Med. 2008;22:587–93.CrossRefPubMed

36.

Abdoli M, Ay MR, Ahmadian A, Zaidi H. A virtual sinogram method to reduce dental metallic implant artefacts in computed tomography-based attenuation correction for PET. Nucl Med Commun. 2010;31:22–31.CrossRefPubMed

37.

Kamel EM, Burger C, Buck A, von Schulthess GK, Goerres GW. Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol. 2003;13:724–8.CrossRefPubMed

38.

Harnsberger HR. Handbook of head and neck imaging. 2nd ed. St. Louis: Mosby-Year Book, Inc; 1994.

39.

Morimoto Y, Tanaka T, Yamamoto N, Kodama M, Seta Y, Habu M, et al. New trends and advances in oral and maxillofacial imaging. Curr Med Imaging Rev. 2009;5:226–37.CrossRef

40.

Liao CT, Wang HM, Chang JT, Lin CY, Ng SH, Huang SF, et al. Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010;77:421–9.CrossRefPubMed

41.

Liao CT, Chang JT, Wang HM, Ng SH, Huang SF, Chen IH, et al. Preoperative [¹⁸F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse. Eur J Nucl Med Mol Imaging. 2009;36:1783–93.CrossRefPubMed

42.

Goerres GW, Schmid DT, Grätz KW, von Schulthess GK, Eyrich GK. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 2003;39:547–51.CrossRefPubMed

Titel: Basic and important points regarding the diagnosis of oral cancers using fluorine-18-labeled fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography: a review
verfasst von: Shinji Kito
Hirofumi Koga
Masafumi Oda
Tatsurou Tanaka
Masaaki Kodama
Manabu Habu
Ikuya Miyamoto
Shinya Kokuryo
Noriaki Yamamoto
Nao Wakasugi-Sato
Shinobu Matsumoto-Takeda
Daigo Yoshiga
Kenji Osawa
Shun Nishimura
Takaaki Joujima
Ken-ichi Mochida
Noriaki Kawanabe
Kou Matsuo
Masataka Uehara
Masaaki Sasaguri
Izumi Yoshioka
Kazuhiro Tominaga
Yasuhiro Morimoto
Publikationsdatum: 27.03.2017
Verlag: Springer Singapore
Erschienen in: Oral Radiology / Ausgabe 3/2017
Print ISSN: 0911-6028
Elektronische ISSN: 1613-9674
DOI: https://doi.org/10.1007/s11282-017-0273-0

Neu im Fachgebiet Zahnmedizin

19.04.2024 | Vorhofflimmern | Nachrichten

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Basic and important points regarding the diagnosis of oral cancers using fluorine-18-labeled fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography: a review

Abstract

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Oxalosis with oral manifestations in a patient with chronic renal failure

Unusual bifid crista galli in a patient with cleft lip and palate

Upper airway imaging in sleep-disordered breathing: role of cone-beam computed tomography

Clinical significance of intraoral strain elastography for diagnosing early stage tongue carcinoma: a preliminary study

Diagnostic value of computed tomography, magnetic resonance imaging, and scintigraphy in diagnosing actinomycosis of the mandible

Artifacts on temporomandibular joint MR images caused by mascara used as hair dye

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter